RxDoctor Payments Data

Catherine Williams

Family · Leesburg, VANPI 1851870786

Payments from drug & device makers

$1,011in general payments, 2019–2025

Across 50 payments — averaging $20.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$265
  • AbbVie$253
  • Amgen$131
  • Astellas Pharma US Inc$120
  • AstraZeneca$46
  • Otsuka America Pharmaceutical, Inc.$41
  • plus $155 from 7 others

What the payments were for

  • Food & beverage$1,011100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,011 in reported general payments places this provider in the 70th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Medicare billing

Part B allowed, 2024
$140,672
Medicare patients
319
Services billed
2,316

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban70$68,048
JardianceEmpagliflozin38$45,625
OzempicSemaglutide35$41,484
XareltoRivaroxaban18$26,889
Breo ElliptaFluticasone/Vilanterol12$8,001
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$4,264
Levothyroxine Sodium212$3,426
Atorvastatin Calcium320$2,997
Rosuvastatin Calcium157$2,192
Risedronate Sodium16$1,729
Estradiol21$1,696
FenofibrateFenofibrate Nanocrystallized21$1,622
Levemir FlexpenInsulin Detemir11$1,565
Ezetimibe43$1,490
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$1,453

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$20$68,04870 claims
Novo NordiskOzempic$265$41,48435 claims
GSKBreo Ellipta$15$8,00112 claims
AbbVieSynthroid$253$86618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,332 family providers in Virginia.

Other family in Leesburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →